Trevena Announces Presentation of Preclinical Data for Delta Receptor Compound TRV250 at International Headache Congress May 14, 2015 7:00 am EDT
Trevena Reports First Quarter 2015 Financial Results and Provides a Corporate Update May 7, 2015 7:00 am EDT
Trevena CMO to Present at the BioCentury 22nd Annual Future Leaders in the Biotech Industry conference Mar 18, 2015 4:30 pm EDT
Trevena to Host Conference Call on March 18th to Discuss Full Year 2014 Financial Results Mar 11, 2015 7:00 am EDT
Trevena completes interim analysis and announces plans for ongoing Phase 2b BLAST-AHF trial of TRV027 in acute heart failure Mar 9, 2015 7:00 am EDT
Trevena CEO to Present at the Cowen and Company 35th Annual Health Care Conference Feb 24, 2015 7:00 am EST